• Company News
  • Food for Thought
  • Calendar & Events
  • Business Life
  • Company News: SuppreMol Appoints Dr. Robert Phelps as Head of Business Development & Licensing


    Monday, February 8, 2010

    SuppreMol GmbH, a privately held biopharmaceutical company developing novel therapeutics for the treatment of autoimmune diseases, today announced that Dr. Robert Phelps has joined the Company as Head of Business Development & Licensing.

    See the full release at SupperMol“s website.

    Post to Twitter

    Leave a Reply


    In order to submit a comment, you need to mention your name and your email address (which won't be published). And ... don't forget your comment!

    Comment Form